Literature DB >> 24372871

Association of greater intravenous volume infusion with shorter hospitalization for patients with post-ERCP pancreatitis.

Sashidhar V Sagi1, Suzette Schmidt, Evan Fogel, Glen A Lehman, Lee McHenry, Stuart Sherman, James Watkins, Gregory A Coté.   

Abstract

BACKGROUND AND AIM: There are no data specifically correlating early intravenous volume infusion (IVI) with the length of hospitalization for postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP).
METHODS: We conducted a retrospective cohort study of patients admitted within 24 h after ERCP to our institute with PEP. IVI during the first 24 h after ERCP was assessed. Primary outcome was severity of PEP, defined by length of hospitalization according to consensus guidelines: mild ≤ 3, moderate 4-10, and severe > 10 days.
RESULTS: Of 72 eligible patients, 41 (56.9%) had mild and 31 (43.1%) moderate/severe PEP. Both groups had comparable demographics, indications, and procedural factors except patients with moderate/severe PEP were older (median age 49 vs 36 years, P = 0.05) and more likely to be discharged and readmitted within the first 24 h (41.9% vs 14.6%, P < 0.01). Patients with mild PEP received significantly greater IVI during the first 24 h (2834 mL [2046, 3570] vs 2044 mL [1227, 2875], P < 0.02) and 50% more fluid post-ERCP (2270 mL [1435, 2961] vs 1515 [950-2350], P < 0.02) compared with those with at least moderate PEP.
CONCLUSION: In patients with PEP, greater IVI during the first 24 h after ERCP is associated with reduced length of hospitalization. Lower IVI was more commonly observed in individuals who were discharged and then readmitted during the first 24 h.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  endoscopic retrograde cholangiopancreatography; intravenous infusion; pancreatitis

Mesh:

Substances:

Year:  2014        PMID: 24372871     DOI: 10.1111/jgh.12511

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Development and Validation of a Prediction Model for Admission After Endoscopic Retrograde Cholangiopancreatography.

Authors:  Gregory A Coté; Sheryl Lynch; Jeffery J Easler; Alyson Keen; Patricia A Vassell; Stuart Sherman; Siu Hui; Huiping Xu
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-27       Impact factor: 11.382

2.  Continuous Infusion of Fluid Hydration Over 24 Hours Does Not Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.

Authors:  Arunchai Chang; Nonthalee Pausawasdi; Phunchai Charatcharoenwitthaya; Uayporn Kaosombatwattana; Tassanee Sriprayoon; Julajak Limsrivilai; Varayu Prachayakul; Somchai Leelakusolvong
Journal:  Dig Dis Sci       Date:  2021-10-15       Impact factor: 3.487

3.  Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Shiro Hayashi; Tsutomu Nishida; Hiromi Shimakoshi; Akiyoshi Shimoda; Takahiro Amano; Aya Sugimoto; Kei Takahashi; Kaori Mukai; Tokuhiro Matsubara; Masashi Yamamoto; Sachiko Nakajima; Koji Fukui; Masami Inada
Journal:  World J Gastrointest Endosc       Date:  2016-12-16

Review 4.  Recent advances in understanding and managing acute pancreatitis.

Authors:  Amar Mandalia; Erik-Jan Wamsteker; Matthew J DiMagno
Journal:  F1000Res       Date:  2018-06-28

5.  The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients.

Authors:  Morteza Aghajanpoor Pasha; Pegah Eslami; Arash Dooghaie Moghadam; Bobak Moazzami; Sajad Shojaee; Faezeh Almasi; Narjes Tavakolikia; Mohsen Norouzinia; Ebrahim Radinnia; Amir Sadeghi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020

6.  Which Patients with Mild Acute Pancreatitis Require Prolonged Hospitalization?

Authors:  Harkirat Singh; Amir Gougol; Rawad Mounzer; Dhiraj Yadav; Efstratios Koutroumpakis; Adam Slivka; David C Whitcomb; Georgios I Papachristou
Journal:  Clin Transl Gastroenterol       Date:  2017-12-07       Impact factor: 4.488

7.  Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.

Authors:  Xavier J N M Smeets; David W da Costa; Paul Fockens; Chris J J Mulder; Robin Timmer; Wietske Kievit; Marieke Zegers; Marco J Bruno; Marc G H Besselink; Frank P Vleggaar; Rene W M van der Hulst; Alexander C Poen; Gerbrand D N Heine; Niels G Venneman; Jeroen J Kolkman; Lubbertus C Baak; Tessa E H Römkens; Sven M van Dijk; Nora D L Hallensleben; Wim van de Vrie; Tom C J Seerden; Adriaan C I T L Tan; Annet M C J Voorburg; Jan-Werner Poley; Ben J Witteman; Abha Bhalla; Muhammed Hadithi; Willem J Thijs; Matthijs P Schwartz; Jan Maarten Vrolijk; Robert C Verdonk; Foke van Delft; Yolande Keulemans; Harry van Goor; Joost P H Drenth; Erwin J M van Geenen
Journal:  Trials       Date:  2018-04-02       Impact factor: 2.279

8.  Fluid type and volume reduce risk of post-ERCP pancreatitis and length of hospital stay in high-risk patients: a secondary analysis of the INDIEH trial.

Authors:  Rupjyoti Talukdar; Ayesha Kamal; Venkata S Akshintala; Rajesh Goud; Sundeep Lakhtakia; Mohan K Ramchandani; Manu Tandan; G V Rao; Zaheer Nabi; Rajesh Gupta; Rakesh Kalapala; Jahangeer Basha; Manohar Reddy; Vijay K Rai; Mahesh K Goenka; Saroj Sinha; Rakesh Kochhar; B Joseph Elmunzer; Mouen A Khashab; Anthony N Kalloo; Vikesh K Singh; D Nageshwar Reddy
Journal:  Endosc Int Open       Date:  2020-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.